Svt heart treatment
Pro Research Analysisby 
Searched over 200M research papers
Treatment Options for Supraventricular Tachycardia (SVT)
Supraventricular tachycardia (SVT) is a common heart rhythm disorder that can cause significant discomfort and distress. Effective management of SVT involves a variety of treatment strategies, ranging from non-pharmacologic interventions to advanced pharmacologic therapies and catheter ablation. This article synthesizes recent research findings on the treatment of SVT.
Valsalva Manoeuvre and Valsalva Assist Device (VAD)
Valsalva Manoeuvre (VM) for SVT
The Valsalva Manoeuvre (VM) is a first-line, non-pharmacologic treatment recommended internationally for SVT. However, its success rate in normal practice is relatively low . Recent modifications to the VM, such as the use of a manometer-controlled 40 mmHg strain, have shown improved cardioversion rates of up to 50% .
Valsalva Assist Device (VAD)
To enhance the effectiveness of VM, a Valsalva Assist Device (VAD) has been developed. This device is designed to provide consistent 40 mmHg strain resistance, making it more practical for out-of-hospital use. Preliminary trials indicate that the VAD could potentially reduce the need for hospital conveyance and more invasive treatments 15.
Pharmacologic Treatments
Adenosine
Adenosine is a widely used first-line pharmacologic treatment for SVT. It is typically administered intravenously in emergency settings. Studies have shown that adenosine is effective in terminating SVT, with a success rate of around 75% to 91.7% depending on the administration technique 23. The double-syringe technique (DST) and single-syringe technique (SST) have both been found effective, with no significant difference in complication rates .
Diltiazem vs. Adenosine
Calcium channel blockers like diltiazem have been found to be more effective than adenosine in some cases. A study comparing the two drugs found that diltiazem had a 100% conversion rate compared to 76.9% for adenosine, with minimal adverse events . This suggests that diltiazem may be a superior option for some patients.
Propranolol for Postoperative SVT
For the prevention of postoperative SVT, low-dose propranolol has been shown to be more effective than diltiazem. In a study involving patients undergoing coronary artery bypass grafting, propranolol significantly reduced the incidence of SVT compared to diltiazem and control groups .
Ivabradine for Refractory SVT
Ivabradine, although primarily used for coronary artery disease and heart failure, has shown promise in treating refractory SVT in pediatric patients. In a small observational study, ivabradine successfully reverted SVT to sinus rhythm in 66% of cases .
Paramedic-Delivered Treatment
Paramedic-Delivered Adenosine
A randomized controlled trial found that paramedics could effectively and safely administer adenosine to treat SVT, with an 81% success rate in terminating tachycardia. This approach also reduced discharge times and healthcare costs compared to conventional emergency department care .
Catheter Ablation
ESC Guidelines on Catheter Ablation
The 2019 European Society of Cardiology (ESC) guidelines have elevated the recommendation for catheter ablation as a curative treatment for most types of SVT to a Class 1 level of evidence. This reflects the extensive literature supporting its efficacy and safety . Catheter ablation is now considered a primary treatment option for many patients, especially those with frequent or severe symptoms.
Conclusion
The management of SVT involves a range of treatment options, from non-pharmacologic interventions like the Valsalva Manoeuvre and Valsalva Assist Device to pharmacologic treatments such as adenosine, diltiazem, and propranolol. Paramedic-delivered adenosine and catheter ablation are also effective strategies. The choice of treatment depends on the patient's specific condition, the severity of symptoms, and the setting in which care is provided. Advances in these treatment modalities continue to improve outcomes for patients with SVT.
Sources and full results
Most relevant research papers on this topic
Safety and efficacy of paramedic treatment of regular supraventricular tachycardia: a randomised controlled trial
Paramedic-delivered adenosine treatment for supraventricular tachycardia is effective, safe, and potentially cost-effective, with potential for reduced healthcare costs without compromising patient care.
Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting.
Low-dose propranolol is a safe and effective drug prophylaxis to avoid supraventricular tachyarrhythmias after coronary bypass surgery.
DOI